Overview

Evaluation of the Condition of Rheumatoid Arthritis After Treatment

Status:
Recruiting
Trial end date:
2025-03-01
Target enrollment:
Participant gender:
Summary
To examine the safety and effectiveness after Xeljanz treatment in rheumatoid arthritis patients
Phase:
Phase 4
Details
Lead Sponsor:
Shinshu University
Collaborator:
Showa Inan General Hospital
Treatments:
Tofacitinib